Skip to main content
. 2016 Nov 10;11(11):e0165983. doi: 10.1371/journal.pone.0165983

Fig 1. Necroptosis signaling pathway and selectivity of compounds in this study for one or more kinases with this pathway.

Fig 1

(A) Necroptosis signaling pathway includes RIPK1, RIPK3 and MLKL (B) Analysis of cpd 1% inhibition of 403 non-mutant kinases when tested at 1 μM concentration (the size of the red circle indicates a higher % inhibition). (C) Cpd 4 inhibits none of the 403 non-mutant kinases when tested at 1 μM concentration, but does inhibit pseudokinase MLKL.